TrialThe Lancet. Infectious diseases2022

Head-to-head comparison of the immunogenicity of RotaTeq and Rotarix rotavirus vaccines and factors associated with seroresponse in infants in Bangladesh: a randomised, controlled, open-label, parallel, phase 4 trial.

Daniel E Velasquez-Portocarrero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.